- Home
- MLSS
as 11-14-2024 3:34pm EST
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | LIVINGSTON |
| Market Cap: | 68.2M | IPO Year: | 1995 |
| Target Price: | $1.25 | AVG Volume (30 days): | 129.6K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.52 - $1.10 | Next Earning Date: | 11-22-2024 |
| Revenue: | $8,422,489 | Revenue Growth: | -15.47% |
| Revenue Growth (this year): | -0.71% | Revenue Growth (next year): | 18.88% |
Stock Insider Trading Activity of Milestone Scientific Inc. (MLSS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| OSSER LEONARD | MLSS | Director | Oct 22 '24 | Sell | $0.93 | 107,984 | $100,425.12 | 4,606,882 | |
| McGeehan Michael | MLSS | Director | Sep 24 '24 | Sell | $1.00 | 209 | $209.00 | 595,273 | |
| McGeehan Michael | MLSS | Director | Sep 19 '24 | Sell | $1.00 | 2,800 | $2,800.00 | 595,273 | |
| OSSER LEONARD | MLSS | Director | Aug 21 '24 | Sell | $0.95 | 141,913 | $134,817.35 | 4,606,882 |
Latest Milestone Scientific Inc. News
MLSS Breaking Stock News: Dive into MLSS Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
GlobeNewswire
14 days ago
Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care
GlobeNewswire
a month ago
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medicare Price Assignment
GlobeNewswire
3 months ago
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024
GlobeNewswire
3 months ago
Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
GlobeNewswire
3 months ago
Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida
GlobeNewswire
4 months ago
Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe
GlobeNewswire
4 months ago
Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware
Compare MLSS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MLSS Milestone Scientific Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.